참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | Sodium Hydroxide | HCID 14798 | — |
| 반응물 | HCID 68777995 | HCID 68777995 | — |
| 용매 | Water | HCID 962 | — |
| 생성물 | 1-[4-(2,4-Difluorophenyl)-1,3-thiazol-2-yl]piperazine | HCID 61779838 | 73.7% |
반응 단계
A 4 N solution (50 ml) of hydrogen chloride in ethyl acetate was added to a solution of tert-butyl 4-[4-(2,4-difluorophenyl)-1,3-thiazol-2-yl]piperazine-1-carboxylate (3.80 g, 9.96 mmol) in ethyl acetate (100 ml), and the mixture was stirred at room temperature for 14 hours. Hexane was poured to the reaction mixture, and crystals were collected by filtration to give 1-[4-(2,4-difluorophenyl)-1,3-thiazol-2-yl]piperazine hydrochloride. The hydrochloride was dissolved in water, neutralized with a 1 N sodium hydroxide aqueous solution, and extracted with chloroform. The extract was washed with water, and dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure to give 2.06 g, (73.7%) of the desired product as a solid.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US07851473B2 |
|---|
| 출처 데이터셋 | uspto-grants-2010_12 |
|---|
| ORD ID | ord-fde286ae357d4823895099c4060a0238 |
|---|
| 출처 메모 | uspto-grants-2010_12 |
|---|